Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1279579

registered interest
date	22/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many doses of the (a) Pfizer-BioNTech and (b) Oxford-AstraZeneca vaccine are physically present in the UK and being held in storage, yet to be deployed or prepared for delivery.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	141990
answer	answer is ministerial correction date of answer 27/01/2021 answer text <p>The Government has procured 40 million doses of the Pfizer/BioNTech and 100 million doses of the Oxford University/AstraZeneca vaccines.</p><p> </p><p>The UK was the first country in the world to start a vaccination programme using these vaccines. As of 26 January 2021, over 6.85 million people across the UK have been vaccinated with the first dose of the vaccine. We continue to work to meet our target of vaccinating all four priority groups by 15 February.</p><p> </p><p>Vaccines are a precious resource in very high demand across the world; therefore, for security reasons it is not possible to provide detail about the size of our supplies and exact detail about deliveries.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/01/2021 17:19:30 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1279585

registered interest
date	22/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many additional cold chain storage refrigerators capable of safely storing the Pfizer-BioNTech vaccine have been (a) ordered, (b) delivered and (c) deployed by the Government in each month since 1 September 2020.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	141991
answer	answer is ministerial correction date of answer 27/01/2021 answer text <p>Public Health England (PHE) secured 58 ultra-low temperature (ULT) freezers which provide sufficient storage for approximately five million doses of potential COVID-19 vaccines which require ULT storage. These ULT freezers were in place, commissioned and ready to receive vaccine prior to the commencement of the programme at the beginning of December 2020. The ULT freezers are for PHE to manage the national storage of COVID-19 vaccines which require storage at -70°C. The National Health Service has secured its own ULT freezers to support local storage.</p><p>PQ141991</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/01/2021 17:07:52 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1279593

registered interest
date	22/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many UK based manufacturing facilities are capable of re-engineering and manufacturing (a) mRNA, (b) viral vector, (c) whole virus and (d) protein subunit vaccines to address emerging variants of the covid-19 virus.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	141992
answer	answer is ministerial correction date of answer 27/01/2021 answer text <p>The Government has made several strategic investments in UK vaccine manufacturing capabilities to increase its capacity, ensuring we are able to manufacture across different vaccine technologies and embed resilience. This includes:</p><p> </p><ul><li>The acceleration and expansion of flexible vaccine manufacturing capabilities at the UK’s first Vaccine Manufacturing and Innovation Centre (VMIC) in Harwell.</li><li>Collaborating with the Cell and Gene Therapy Catapult to fund a state-of-the-art Manufacturing Innovation Centre in Braintree.</li><li>Expansion of the Valneva factory in Livingston, Scotland, which is capable of whole virus manufacture.</li></ul><p> </p><p>Both the VMIC and Braintree sites are flexible to vaccine types, including messenger RNA (mRNA), viral vector, and protein sub-unit. These sites could have a role in providing capability to manufacture vaccines to address the emerging variants of the COVID-19 virus.</p><p> </p><p>The Government has also invested through UK Research and Innovation (UKRI) to support the creation of a new Centre of Excellence in mRNA vaccine manufacture at the Centre for Process Innovation (CPI), with equipment that can manufacture mRNA for vaccines. This funding has upgraded CPI’s National Biologics Manufacturing Centre at Darlington to obtain good manufacturing practice certification for the manufacture of RNA products including mRNA for clinical trials. A key advantage of RNA vaccines is how quickly they can be developed compared with other platforms.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/01/2021 17:18:03 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1279169

registered interest
date	21/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many (a) Pfizer/BioNTech and (b) Oxford-AstraZeneca vaccines have been procured by the UK Government; how many of each vaccine have reached the UK to date; and if he will publish the number of doses of each vaccine which have been distributed to (a) England, (b) Wales, (c) Scotland and (d) Northern Ireland to date.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	141584
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>The Government has procured 40 million doses of the Pfizer/BioNTech and 100 million doses of the AstraZeneca/University of Oxford vaccines.</p><p> </p><p>The UK was the first country in the world to start a vaccination programme using these vaccines. Due to our swift and decisive action there has been a regular and steady supply of vaccine doses arriving into the UK since early December 2020.</p><p> </p><p>As of 20 January 2021, almost five million people across the UK have been vaccinated with the first dose of the vaccine. We continue to work to meet our target of vaccinating all four priority groups, as advised by the Joint Committee on Vaccination and Immunisation, by the middle of February.</p><p> </p><p>Vaccines are a precious resource in very high demand across the world; therefore, for security reasons it is not possible to provide detail about the size of our supplies and exact detail about deliveries.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/01/2021 16:17:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4630 label Biography information for Ben Lake

1279246

registered interest
date	21/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS healthcare workers had received the (a) first and (b) second dose of the covid-19 vaccine by Wednesday 20 January 2021.
tabling member constituency	Brent North
tabling member printed	Barry Gardiner
uin	141386
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>This information is not available in the format requested.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 141387 question first answered 26/01/2021 17:16:03 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 77316 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	146 label Biography information for Barry Gardiner

1279257

registered interest
date	21/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many non-frontline workers in the NHS had received a (a) first dose and (b) second dose of the covid-19 vaccine by 5pm on 20 January 2021.
tabling member constituency	Brent North
tabling member printed	Barry Gardiner
uin	141387
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>This information is not available in the format requested.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 141386 question first answered 26/01/2021 17:16:03 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 77315 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	146 label Biography information for Barry Gardiner

1279278

registered interest
date	21/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answers of 19 January 2021 to Questions 137942 and 137941, if he will provide a breakdown of the £300 million invested in securing and scaling up UK manufacturing capacity by (a) type of capacity, (b) geographical location and (c) the date that investment was delivered.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	141474
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>The Government invested over £300 million in 2020 to secure and scale-up the UK’s manufacturing capabilities to respond to this pandemic, including:</p><p>- £127 million towards the Cell and Gene Therapy Catapult Braintree in Essex;</p><p>- £93 million to accelerate the completion and expanded role of the Vaccine Manufacturing Innovation Centre in Oxfordshire;</p><p>- £4.7 million for skills training through the Advanced Therapies Skills Training Network, which will be delivered through both virtual and physical centres;</p><p>- £8.75 million for the set-up of the rapid deployment facility at Oxford Biomedica in Oxfordshire; and</p><p>- £65.5 million for the manufacture of the University of Oxford / AstraZeneca vaccine.</p><p> </p><p>In addition to the above, we have also funded the fill and finish of vaccines through a contract with Wockhardt in Wrexham, North Wales, as well as the expansion of the Valneva factory in Livingston, Scotland. However, we are not able to give further details on these two developments owing to commercial confidentiality.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/01/2021 16:15:42 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1279279

registered interest
date	21/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to secure UK covid-19 vaccine manufacturing capacity and protect those manufacturing establishments from flood, fire, malfunction and other security threats.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	141475
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>The Government takes security extremely seriously and is ensuring all necessary steps are taken.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/01/2021 16:08:01 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1279295

registered interest
date	21/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of prioritising the covid-19 vaccine for full time unpaid carers of elderly relatives or those who are shielding.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	141579
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who advise the Government on which vaccines the United Kingdom should use and provide advice on prioritisation at a population level.  For the first phase, the JCVI have advised that the vaccine be given to care home residents and staff, as well as frontline health and social care workers, then to the rest of the population in order of age and clinical risk factors.</p><p> </p><p>Those who are in receipt of a carer’s allowance, or those who are the main carer of an elderly or disabled person whose welfare may be at risk if the carer falls ill, should also be offered vaccination in priority group six. This includes unpaid carers.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/01/2021 17:21:26 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 77317 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4610 label Biography information for Bambos Charalambous

1279312

registered interest
date	21/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what proportion of the ministerial work of the Parliamentary Under Secretary of State (Minister for Business and Industry) comprises overseeing the (a) Vaccine taskforce and (b) Covid-19 vaccination programme.
tabling member constituency	Hazel Grove
tabling member printed	Mr William Wragg
uin	141506
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>I am fully committed to ensuring that the entire adult UK population has been offered a vaccine by Autumn 2021. We are working hard to meet the initial target of offering a first dose to all those in priority cohorts 1 to 4, as advised by the Joint Committee on Vaccination and Immunisation, by 15<sup>th</sup> February.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/01/2021 11:15:07 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4429 label Biography information for Mr William Wragg